The FTC has launched an on-site investigation into Ottogi and Guangdong Pharmaceutical on charges of unfair internal transactions

Reporter Kim Jisun / approved : 2023-09-15 03:00:30
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] The Fair Trade Commission has launched an investigation into allegations of unfair support by mid-sized companies such as Ottogi and Kwangdong Pharmaceutical.

According to the industry, the FTC sent investigators to Ottogi and Guangdong Pharmaceutical on the 14th.

The FTC is said to have detected allegations of unfair support from a number of groups as a result of monitoring the status of internal transactions by mid-sized business groups.

Mid-sized business groups have lax external monitoring and a higher proportion of the total family members within the board of directors than large business groups with assets of 5 trillion won or more.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years2025.11.07
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations2025.11.07
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom2025.11.07
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking2025.11.07
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사